Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Krejci, Marta  [Clear All Filters]
2023
Kovacsova F, Folber F, Weinbergerova B, Stepanova R, Kabut T, Tomiska M, Krejci M, Mayer J. Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use. Ann Hematol. 2023.
2020
Robesova B, Drncova M, Folta A, Krejci M, Folber F, Sustkova Z, Mayer J, Jeziskova I. Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR. Bone Marrow Transplant. 2020.
2016
Adam Z, Pour L, Krejci M, Ševčíková S, Pourová E, Ševčíková E, Král Z, Mayer J. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience]. Vnitr Lek. 2016;62(1):25-39.
2015
Minarik J, Pavlicek P, Pour L, Pika T, Maisnar V, Spicka I, Jarkovsky J, Krejci M, Bacovsky J, Radocha J, et al. Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy. PLoS One. 2015;10(4):e0123866.
2013
Krejci M, Doubek M, Dusek J, Brychtova Y, Racil Z, Navratil M, Tomiska M, Horky O, Pospisilova S, Mayer J. Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. Ann Hematol. 2013.